Table 4.
Intervention | Control | Both groups | |
---|---|---|---|
All participants | |||
No in group | 1179 | 1176 | 2355 |
HR (95% CI), P value: | |||
Crude† | 1.45 (1.27 to 1.66), <0.001 | 1.44 (1.17 to 1.76), <0.001 | 1.39 (1.23 to 1.58), <0.001 |
Adjusted‡ | 1.22 (1.04 to 1.44), 0.016 | 1.28 (1.09 to 1.51), 0.003 | 1.22 (1.14 to 1.32), <0.001 |
Sensitivity§ | 1.20 (1.03 to 1.41), 0.023 | 1.32 (1.11 to 1.57), 0.002 | 1.24 (1.15 to 1.33), <0.001 |
Participants aged <65 | |||
No in group | 886 | 874 | 1760 |
HR (95% CI), P value: | |||
Crude† | 1.02 (0.60 to 1.73), 0.936 | 1.17 (0.82 to 1.69), 0.389 | 1.07 (0.93 to 1.23), 0.368 |
Adjusted‡ | 0.92 (0.61 to 1.37), 0.680 | 1.12 (0.79 to 1.57), 0.525 | 1.01 (0.88 to 1.16), 0.924 |
Sensitivity§ | 0.94 (0.58 to 1.53), 0.816 | 1.16 (0.79 to 1.70), 0.448 | 1.02 (0.91 to 1.16), 0.703 |
Participants aged ≥65 | |||
No in group | 293 | 302 | 595 |
HR (95% CI), P value: | |||
Crude† | 1.55 (1.39 to 1.71), <0.001 | 1.53 (1.24 to 1.88), <0.001 | 1.50 (1.31 to 1.71), <0.001 |
Adjusted‡ | 1.42 (1.22 to 1.67), <0.001 | 1.39 (1.10 to 1.76), 0.006 | 1.35 (1.18 to 1.54), <0.001 |
Sensitivity§ | 1.36 (1.17 to 1.58), <0.001 | 1.43 (1.14 to 1.78), 0.002 | 1.35 (1.19 to 1.53), <0.001 |
*Cox regressions for death as function of time varying serum cholesterol concentration. All estimates represent hazard ratio for a serum cholesterol decrease of 30 mg/dL (0.78 mmol/L). All models account for clustering within hospital.
†Model adjusted for baseline serum cholesterol concentration.
‡Adjusted for baseline serum cholesterol concentration, age, BMI, sex, adherence to diet, and systolic blood pressure (SBP).
§Further adjusted for time varying percentage change from baseline for BMI and SBP.